ЕПІРУБІЦИНУ ГІДРОХЛОРИД

उत्पाद अवलोकन

About ЕПІРУБІЦИНУ ГІДРОХЛОРИД

ЕПІРУБІЦИНУ ГІДРОХЛОРИД is a medication containing the active ingredient Epirubicin, a synthetic anthracycline antibiotic used in the treatment of various types of cancer, including breast cancer, ovarian cancer, and lymphomas. It works by intercalating DNA strands, thereby inhibiting the synthesis of nucleic acids and inducing apoptosis in rapidly dividing cancer cells.

Key Benefits & Uses

• Treatment of breast cancer, particularly in patients with metastatic disease or those who have not responded to other therapies.
• Treatment of ovarian cancer, particularly in patients with advanced or recurrent disease.
• Treatment of lymphomas, particularly in patients with Hodgkin's lymphoma or non-Hodgkin's lymphoma.

Active Ingredient & Action

Epirubicin is a topoisomerase II inhibitor that works by binding to DNA and preventing the enzyme topoisomerase II from unwinding DNA strands. This leads to the formation of DNA breaks, which ultimately triggers apoptosis in cancer cells. Epirubicin also has a cytotoxic effect on rapidly dividing cells, making it effective against a range of cancer types.

Important Notes

ЕПІРУБІЦИНУ ГІДРОХЛОРИД should only be used under the guidance of a qualified healthcare professional. Common side effects include myelosuppression, alopecia, and mucositis. Patients should be monitored for signs of cardiac toxicity, and the medication should be used with caution in patients with pre-existing heart conditions. It is essential to follow the recommended dosing schedule and to report any adverse effects promptly to a healthcare professional.